Aldo M. Denti joins Dentsply Sirona as Executive Vice President and Chief Commercial Officer (CCO), effective October 6, 2025. The appointment is designed to sharpen the company’s focus on the customer by aligning its Global Business Units and Commercial Organizations more closely—streamlining how Dentsply Sirona works and delivers.
Mr. Denti is a global business leader with over 25 years of experience driving transformative growth in the Medical Device and Consumer Health sectors. His expertise spans sales, marketing, strategic planning, and successful integration across diverse markets. Mr. Denti has a proven track record of delivering revenue growth and operational efficiency. Most recently, he served as Company Group Chairman, Global Orthopedics, at Johnson & Johnson MedTech.
“I am pleased to welcome Aldo as our new CCO and rejoin forces with him,” said Daniel Scavilla, president and CEO of Dentsply Sirona. “Aldo is a results-oriented innovator with exceptional leadership in navigating dynamic, fast-paced environments and engaging stakeholders worldwide. His expertise will strengthen collaboration across business units and regions, unlock synergies, and support global revenue growth by leveraging our unique portfolio of products and solutions. Aldo will lead our global sales strategy and execution to deliver superior growth, profitability, and customer satisfaction across all regions. Additionally, by bringing our Global Business Units and Commercial Organizations even closer together, the new CCO role will drive a strong focus on the customer and the customer experience. Our new structure will simplify how we work and allow for faster execution.”
Mr. Denti said, “I am honored to join Dentsply Sirona at such an exciting time for the company. Together with the team, I look forward to advancing our operational goals while strengthening our commercial execution. I strongly believe in the potential of Dentsply Sirona as the world’s largest diversified manufacturer in the dental industry and we will execute on key strategic growth drivers across regions.”
About Aldo M. Denti
Mr. Denti was most recently Company Group Chairman, Global Orthopedics, at Johnson & Johnson MedTech, a main segment of Johnson & Johnson, one of the world’s largest healthcare companies. Prior to this role, Mr. Denti served as Vice President, Global Franchise, of Johnson & Johnson Vision. Earlier in his career, he held various leadership roles in EMEA for the Johnson & Johnson orthopedics business and other sales and marketing roles outside Johnson & Johnson. He began his professional path with Pfizer, progressing through sales and marketing leadership roles in Switzerland, the UK, and the US. He later worked for Medtronic and Wright Medical in Europe and the US. Mr. Denti speaks six languages and holds a bachelor’s degree with honors from York University in Toronto, Canada, and completed Executive Education Programs at Harvard Business School.
About Dentsply Sirona
Dentsply Sirona is the world’s largest diversified manufacturer of professional dental products and technologies, with over a century of innovation and service to the dental industry and patients worldwide. Dentsply Sirona develops, manufactures, and markets a comprehensive solutions offering including dental and oral health products as well as other consumable medical devices under a strong portfolio of world-class brands.
Dentsply Sirona’s innovative products provide high-quality, effective, and connected solutions to advance patient care and deliver better and safer dental care. Dentsply Sirona’s headquarters is located in Charlotte, North Carolina. The company’s shares are listed in the United States on Nasdaq under the symbol XRAY.
Visit www.dentsplysirona.com for more information about Dentsply Sirona and its products.
DISCLAIMER
This information and any attachment thereto contains “forward-looking statements” within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Such statements are not guarantees of future performance. These forward-looking statements reflect views and assumptions regarding expectations and projections about future events and are based on currently available information or information available on the date of any document incorporated by reference. You can generally identify these forward-looking statements by the use of words such as “may,” “could,” “estimate,” “will,” “believe,” “anticipate,” “think,” “intend,” “expect,” “project,” “plan,” “target,” “forecast”, and similar words and expressions. However, these words are not the exclusive means of identifying such statements.
In addition, any statements that refer to expectations, projections, or other characterizations of future events or circumstances are forward-looking statements and may include statements relating to future revenues, expenses, margins, profitability, net income/(loss), earnings per share, and other measures of results of operations and the prospects of future growth of our business. These forward-looking statements are inherently subject to uncertainties, risks, and changes in circumstances that are difficult to predict. For a discussion of such risks, uncertainties, and other matters that could cause actual results to differ materially, including risks relating to, among other factors, the market for dental products and services, pricing, future sales volume of the company’s products, the possibility of changing economic, market, and competitive conditions, dependence on products, dependence on key personnel, technological developments, intense competition, market uncertainties, dependence on distributors, ability to manage growth, dependence on key suppliers, dependence on key members of management, government regulation, our ability to integrate the businesses of Dentsply Sirona, acquisitions and affiliations, readers are urged to carefully review and consider various disclosures made by the company and Dentsply Sirona in their public filings, including in their Annual Reports on Form 10-K and in their reports on Forms 10-Q and 8-K filed with the Securities and Exchange Commission.
Readers are cautioned not to place undue reliance on such statements, which speak only as of the date hereof. Except as required by law, the company does not assume any obligation to update any forward-looking statements contained in this document or the attachments to reflect new information or future events or developments after the date any such statement is made.
Registered brands, trade names, and logos are used. Even in particular cases, when they appear without a TM or ®, all corresponding legal rules and provisions apply. All rights are retained by Dentsply Sirona. Clinicians may have been compensated for use of their experiences and testimonials. Due to the different approval and registration times, not all technologies and products are immediately available in all countries. Please reach out to a local dealer or sales representative for more information.
